Article info
PDFRheumatoid arthritis
Original article
Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
- Correspondence to Professor Andrea Rubbert-Roth; andrea.rubbert{at}medizin.uni-koeln.de
Citation
Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
Publication history
- Received November 17, 2015
- Revision received April 14, 2016
- Accepted April 19, 2016
- First published May 10, 2016.
Online issue publication
July 18, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/